GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BriaCell Therapeutics Corp (TSX:BCT) » Definitions » Price-to-Tangible-Book

BriaCell Therapeutics (TSX:BCT) Price-to-Tangible-Book : (As of Apr. 25, 2024)


View and export this data going back to 2006. Start your Free Trial

What is BriaCell Therapeutics Price-to-Tangible-Book?

As of today (2024-04-25), BriaCell Therapeutics's share price is C$3.00. BriaCell Therapeutics's Tangible Book per Share of Jan. 2024 for the quarter that ended in Jan. 2024 was C$-0.70. Hence, BriaCell Therapeutics's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for BriaCell Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, BriaCell Therapeutics's highest Price to Tangible Book Ratio was 146.67. The lowest was 0.32. And the median was 10.03.

TSX:BCT's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.67
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, BriaCell Therapeutics's share price is C$3.00. BriaCell Therapeutics's Book Value per Sharefor the quarter that ended in Jan. 2024 was C$-0.68. Hence, BriaCell Therapeutics's P/B Ratio of today is .


BriaCell Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for BriaCell Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BriaCell Therapeutics Price-to-Tangible-Book Chart

BriaCell Therapeutics Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 2.85 9.95 -

BriaCell Therapeutics Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 27.44 -

Competitive Comparison of BriaCell Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, BriaCell Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BriaCell Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BriaCell Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where BriaCell Therapeutics's Price-to-Tangible-Book falls into.



BriaCell Therapeutics Price-to-Tangible-Book Calculation

BriaCell Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jan. 2024 )
=3.00/-0.695
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


BriaCell Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of BriaCell Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


BriaCell Therapeutics (TSX:BCT) Business Description

Traded in Other Exchanges
Address
235 - 15th Street, Suite 300, West Vancouver, 3rd Floor, Bellevue Centre, Vancouver, BC, CAN, V7T 2X1
BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.

BriaCell Therapeutics (TSX:BCT) Headlines

No Headlines